UK markets closed

Ocugen, Inc. (OCGN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.32-0.14 (-1.65%)
At close: 4:00PM EDT
8.40 +0.08 (+0.96%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close8.46
Bid8.38 x 3100
Ask8.40 x 4000
Day's range7.75 - 8.39
52-week range0.25 - 18.77
Avg. volume16,025,148
Market cap1.654B
Beta (5Y monthly)4.30
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    7 Reasons Why Novavax Is a No-Brainer Pick Over Ocugen

    Ocugen's share price has skyrocketed roughly seven times more than Novavax's has. Does that make Ocugen the smarter vaccine stock to buy right now? Here are seven reasons why Novavax stock is a no-brainer pick over Ocugen.

  • Motley Fool

    3 Under-the-Radar COVID Stocks

    What's really interesting about the stock market is there are always new companies trying new things. And sometimes the stocks of these companies come out of nowhere and blow the market averages away.

  • Motley Fool

    3 Biotech Stocks That Are Ridiculously Overpriced

    Beauty is in the eye of the beholder -- and, in many cases, so is the appropriate valuation of a stock. Here's why they picked Cassava Sciences (NASDAQ: SAVA), Ocugen (NASDAQ: OCGN), and Moderna (NASDAQ: MRNA). Prosper Junior Bakiny (Cassava Sciences): Investors have been flocking to this clinical-stage biotech all year long, pushing its share price up by well over 600%.